A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01149291
Recruitment Status : Completed
First Posted : June 23, 2010
Last Update Posted : January 12, 2015
Information provided by (Responsible Party):
AbbVie ( AbbVie (prior sponsor, Abbott) )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2014
  Actual Study Completion Date : December 2014